The University of Chicago Header Logo

Connection

Daniel Arber to Chromosome Aberrations

This is a "connection" page, showing publications Daniel Arber has written about Chromosome Aberrations.
Connection Strength

3.055
  1. Prognostic Significance of Complex Karyotypes in Acute Myeloid Leukemia. Curr Treat Options Oncol. 2019 02 11; 20(2):15.
    View in: PubMed
    Score: 0.607
  2. Immunohistochemistry for p53 is a useful tool to identify cases of acute myeloid leukemia with myelodysplasia-related changes that are TP53 mutated, have complex karyotype, and have poor prognosis. Mod Pathol. 2017 03; 30(3):382-392.
    View in: PubMed
    Score: 0.522
  3. High frequency of pro-B acute lymphoblastic leukemia in adults with secondary leukemia with 11q23 abnormalities. Leukemia. 2003 Jun; 17(6):1091-5.
    View in: PubMed
    Score: 0.204
  4. Prognostic impact of acute myeloid leukemia classification. Importance of detection of recurring cytogenetic abnormalities and multilineage dysplasia on survival. Am J Clin Pathol. 2003 May; 119(5):672-80.
    View in: PubMed
    Score: 0.203
  5. Erythroleukemia: an Update. Curr Oncol Rep. 2021 04 20; 23(6):69.
    View in: PubMed
    Score: 0.177
  6. Diagnosis and Treatment of Patients With Acute Myeloid Leukemia With Myelodysplasia-Related Changes (AML-MRC). Am J Clin Pathol. 2020 11 04; 154(6):731-741.
    View in: PubMed
    Score: 0.171
  7. Comparison of therapy-related and de novo core binding factor acute myeloid leukemia: A bone marrow pathology group study. Am J Hematol. 2020 07; 95(7):799-808.
    View in: PubMed
    Score: 0.165
  8. Acute lymphoblastic leukemia. Survey of immunophenotype, French-American-British classification, frequency of myeloid antigen expression, and karyotypic abnormalities in 210 pediatric and adult cases. Am J Clin Pathol. 1999 Apr; 111(4):467-76.
    View in: PubMed
    Score: 0.153
  9. De novo acute myeloid leukemia with 20-29% blasts is less aggressive than acute myeloid leukemia with =30% blasts in older adults: a Bone Marrow Pathology Group study. Am J Hematol. 2014 Nov; 89(11):E193-9.
    View in: PubMed
    Score: 0.111
  10. The differential diagnosis and bone marrow evaluation of new-onset pancytopenia. Am J Clin Pathol. 2013 Jan; 139(1):9-29.
    View in: PubMed
    Score: 0.099
  11. Acute myeloid leukemia. Hematol Oncol Clin North Am. 2009 Aug; 23(4):633-54.
    View in: PubMed
    Score: 0.078
  12. Chromosomal aberrations in a case of synchronous extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue type and bronchogenic adenocarcinoma. Appl Immunohistochem Mol Morphol. 2008 May; 16(3):296-300.
    View in: PubMed
    Score: 0.072
  13. Value of combined morphologic, cytochemical, and immunophenotypic features in predicting recurrent cytogenetic abnormalities in acute myeloid leukemia. Hum Pathol. 2003 May; 34(5):479-83.
    View in: PubMed
    Score: 0.051
  14. Clinicopathologic and Molecular Analysis of Normal Karyotype Therapy-Related and De Novo Acute Myeloid Leukemia: A Multi-Institutional Study by the Bone Marrow Pathology Group. JCO Precis Oncol. 2023 01; 7:e2200400.
    View in: PubMed
    Score: 0.050
  15. 21q22 balanced chromosome aberrations in therapy-related hematopoietic disorders: report from an international workshop. Genes Chromosomes Cancer. 2002 Apr; 33(4):379-94.
    View in: PubMed
    Score: 0.047
  16. Targeting multiple genetic aberrations in isolated tumor cells by spectral fluorescence in situ hybridization. Cancer Detect Prev. 2002; 26(3):171-9.
    View in: PubMed
    Score: 0.046
  17. High-dose cytosine arabinoside and daunorubicin induction therapy for adult patients with de novo non M3 acute myelogenous leukemia: impact of cytogenetics on achieving a complete remission. Leukemia. 2000 Jul; 14(7):1191-6.
    View in: PubMed
    Score: 0.042
  18. A reevaluation of erythroid predominance in Acute Myeloid Leukemia using the updated WHO 2016 Criteria. Mod Pathol. 2018 06; 31(6):873-880.
    View in: PubMed
    Score: 0.035
  19. The immunophenotype of adult acute myeloid leukemia: high frequency of lymphoid antigen expression and comparison of immunophenotype, French-American-British classification, and karyotypic abnormalities. Am J Clin Pathol. 1998 Feb; 109(2):211-20.
    View in: PubMed
    Score: 0.035
  20. Toward the validation of aneusomy detection by fluorescence in situ hybridization in bladder cancer: comparative analysis with cytology, cytogenetics, and clinical features predicts recurrence and defines clinical testing limitations. Clin Cancer Res. 1997 Dec; 3(12 Pt 1):2317-28.
    View in: PubMed
    Score: 0.035
  21. Myelodysplastic Syndrome, Unclassifiable (MDS-U) With 1% Blasts Is a Distinct Subgroup of MDS-U With a Poor Prognosis. Am J Clin Pathol. 2017 Jul 01; 148(1):49-57.
    View in: PubMed
    Score: 0.034
  22. A study of disseminated intravascular coagulation in acute leukemia reveals markedly elevated D-dimer levels are a sensitive indicator of acute promyelocytic leukemia. Int J Lab Hematol. 2017 Aug; 39(4):375-383.
    View in: PubMed
    Score: 0.033
  23. Chromosome 11 abnormalities in Bowen disease of the vulva. Cancer Genet Cytogenet. 1997 Feb; 93(2):109-14.
    View in: PubMed
    Score: 0.033
  24. Numerical cytogenetic abnormalities of chromosomes 3, 7, and 12 in marginal zone B-cell lymphomas. Mod Pathol. 1996 Oct; 9(10):995-1000.
    View in: PubMed
    Score: 0.032
  25. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood. 2009 Jul 30; 114(5):937-51.
    View in: PubMed
    Score: 0.019
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.